Katy Beckermann

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Katy Beckermann
Nov 11, 2024, 11:50 | Societies
Highlights from the 39th Society for Immunotherapy of Cancer Annual Meeting
The 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting was held from November 6–10, 2024,…
Oct 11, 2024, 16:17 | Blog
Katy Beckermann: Defining oligometastatic RCC is challenging
Katy Beckermann, Assistant Professor Of Medicine at Vanderbilt University Medical Center, shared a post on…
Sep 18, 2024, 11:25 | Insight
Toni Choueiri: PEACE-3 phase 3 trials first results at ESMO24
Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X by…
Aug 30, 2024, 16:32 | Blog
Katy Beckermann: Feasibility of an intermittent ipi/nivo approach in their Phase II trial
Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X:…
Aug 15, 2024, 18:25 | Blog
Katy Beckermann: Kidney Cancer Association's Virtual Patient Symposium
Kidney Cancer Association's Virtual Patient Symposium aims to educate patients, caregivers, and the public about…
Jun 27, 2024, 05:29 | Blog
Chandler Park: An honor to co-host with Cathy Eng for the ASCO24 Nashville review
Chandler Park shared on LinkedIn:     . “That was FUN! It was an honor to…
Apr 17, 2024, 19:02 | Blog
Katy Beckermann: Exciting update from Dr. Mike Atkins on the novel checkpoint inhibitor LAG3 and its potential role in kidney cancer treatment
Katy Beckermann, Assistant Professor at Vanderbilt University Medical Center, shared a post by GU Oncology…
All: 7 Posts: 1 - 100
Special Coverage